Grantham, Mayo, Van Otterloo & Co (GMO)’s Innoviva INVA Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio INVA Stock Details INVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-79,000	Closed	-$929K	–	793
2020 Q1	$929K	Buy	+79,000	New	+$1.04M	0.01%	506
2018 Q1	–	Sell	-14,600	Closed	-$207K	–	598
2017 Q4	$207K	Hold	14,600	–	–	﹤0.01%	552
2017 Q3	$206K	Buy	+14,600	New	+$193K	﹤0.01%	538
2014 Q2	–	Sell	-39,960	Closed	-$996K	–	527
2014 Q1	$996K	Sell	39,960 -50,253	-56%	-$1.47M	﹤0.01%	471
2013 Q4	$2.59M	Buy	90,213 +22,653	+34%	+$663K	0.01%	382
2013 Q3	$2.23M	Buy	67,560 +41,747	+162%	+$1.3M	0.01%	397
2013 Q2	$801K	Buy	+25,813	New	+$692K	﹤0.01%	485

Other funds holding INVA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO)'s INVA Position: Q2 2020 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of Innoviva (INVA) in Q2 2020, closing a stake of 79,000 shares — an estimated $929K sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in INVA in Q2 2013 and held it in 7 quarters. The position peaked at $2.59M in Q4 2013. 203 funds tracked by Wall St. Rank hold INVA as of Q2 2020.

Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining Innoviva position as of Q2 2020 after selling out during the quarter.
Grantham, Mayo, Van Otterloo & Co (GMO) sold 79,000 Innoviva shares in Q2 2020, an estimated $929K.
Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Innoviva in Q2 2013 and held it in 7 quarters.
Grantham, Mayo, Van Otterloo & Co (GMO)'s Innoviva position peaked at $2.59M in Q4 2013.
203 funds tracked by Wall St. Rank held Innoviva as of Q2 2020.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q2 2020, filed 13 Aug 2020.